Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Mahzad Akbarpour, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20

Showing 20 citing articles:

Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 80
Bispecific and multispecific antibodies in oncology: opportunities and challenges
Maria-Elisabeth Goebeler, Gernot Stuhler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 7, pp. 539-560
Closed Access | Times Cited: 29
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Regulation of Treg cells by cytokine signaling and co-stimulatory molecules
Yuan Zong, Kaihang Deng, Wai Po Chong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 24
Bispecific antibodies: advancing precision oncology
M. Zurita Herrera, G. Pretelli, Jayesh Desai, et al.
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 893-919
Open Access | Times Cited: 8
Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma
Fereshteh Rezagholizadeh, Fatemeh Tajik, Morteza Talebi Doluee, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
Bispezifische Antikörper in der Therapie hämatologischer Neoplasien und solider Tumoren
Xiang Zhou, Johannes M. Waldschmidt, Hermann Einsele
Deleted Journal (2025)
Open Access
Emerging Immunotherapy Approaches for Treating Prostate Cancer
Lingbin Meng, Yuanquan Yang, Amir Mortazavi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14347-14347
Open Access | Times Cited: 12
Importance of targeting various cell signaling pathways in solid cancers
Chandrayee Ghosh, Jiangnan Hu
International review of cell and molecular biology (2024), pp. 101-155
Closed Access | Times Cited: 1
High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression
Yao‐An Yu, Wan‐Ju Lien, Wen‐Ching Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 1
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Advancements in Understanding the Hide-and-Seek Strategy of Hibernating Breast Cancer Cells and Their Implications in Oncology from a Broader Perspective: A Comprehensive Overview
Aiman Al-Ruwishan, Bushra Amer, Ahmed F. Salem, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8340-8367
Open Access
Bispecific T-Cell Engagers (BiTEs) in Immunotherapy
Mohsen Sheykhhasan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 205-234
Closed Access
Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances
Pooya Farhangnia, Mohammad-Reza Shokri, Mahzad Akbarpour, et al.
Interdisciplinary cancer research (2024)
Closed Access
Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy
Fabio Casciano, Lorenzo Caruso, Enrico Zauli, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2528-2528
Open Access
Next-generation immunotherapy: igniting new hope for lung cancer
Molly Li, Antony C. S. Chan, Kevin Mok, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Engineering antibodies with cancer‐associated binding sites
Yulong Tian, Yun Pan, Yingchun Zhang, et al.
BMEMat (2024)
Open Access
Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors
Pooya Farhangnia, Hossein Khorramdelazad, Pouria Ghiaee, et al.
Interdisciplinary cancer research (2023)
Closed Access
Page 1

Scroll to top